Kewaunee Scientific (NASDAQ:KEQU) Share Price Crosses Above Two Hundred Day Moving Average of $26.84

Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $26.84 and traded as high as $35.95. Kewaunee Scientific shares last traded at $35.70, with a volume of 9,120 shares trading hands.

Analyst Ratings Changes

A number of brokerages have recently weighed in on KEQU. TheStreet downgraded Kewaunee Scientific from a “b-” rating to a “c” rating in a report on Thursday, March 7th. StockNews.com upgraded Kewaunee Scientific from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th.

Kewaunee Scientific Stock Up 3.5 %

The business has a 50 day simple moving average of $32.74 and a 200 day simple moving average of $26.84. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.28 and a quick ratio of 1.76. The stock has a market cap of $101.75 million, a PE ratio of 11.98 and a beta of 0.69.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, March 6th. The technology company reported $0.85 EPS for the quarter. Kewaunee Scientific had a return on equity of 20.82% and a net margin of 4.34%. The firm had revenue of $46.78 million for the quarter.

Insider Buying and Selling at Kewaunee Scientific

In other Kewaunee Scientific news, VP Douglas J. Batdorff sold 3,500 shares of the business’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $31.35, for a total value of $109,725.00. Following the completion of the sale, the vice president now owns 6,167 shares of the company’s stock, valued at $193,335.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Kewaunee Scientific news, VP Douglas J. Batdorff sold 3,500 shares of the business’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $31.35, for a total value of $109,725.00. Following the completion of the sale, the vice president now owns 6,167 shares of the company’s stock, valued at $193,335.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Elizabeth D. Phillips sold 3,277 shares of the business’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $32.50, for a total value of $106,502.50. Following the completion of the sale, the vice president now directly owns 10,263 shares of the company’s stock, valued at approximately $333,547.50. The disclosure for this sale can be found here. Corporate insiders own 14.50% of the company’s stock.

Institutional Trading of Kewaunee Scientific

An institutional investor recently raised its position in Kewaunee Scientific stock. Minerva Advisors LLC increased its holdings in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 0.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 174,432 shares of the technology company’s stock after purchasing an additional 1,513 shares during the period. Kewaunee Scientific makes up approximately 2.0% of Minerva Advisors LLC’s holdings, making the stock its 17th largest position. Minerva Advisors LLC owned 6.01% of Kewaunee Scientific worth $2,843,000 at the end of the most recent quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.